Selank 5mg

CLASSIFICATION Anxiolytic Peptide
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Beligas
WAREHOUSE International Warehouse 3
SUBSTANCE Selank ,

In the ever-evolving field of biotechnology, innovative biologically active substances like "cognitive enhancers" or "nootropics" are gaining traction. Among these, Selank, previously known as ?TP-7,? stands out as a synthetic peptide?a meticulously crafted small protein.

Heralded for its potential as an "anti-anxiety" solution, Selank is believed to elevate learning capabilities and invigorate energy levels, all while boasting minimal side effects and a low risk of addiction.

Developed by the Institute of Molecular Genetics (Russian Academy of Sciences) in collaboration with the V.V. Zakusov Research Institute of Pharmacology, Selank is significantly smaller than most natural proteins. It is designed by combining a peptide sequence from tuftsin, a naturally occurring peptide found in antibodies, with a stability-enhancing sequence.

Research indicates that both tuftsin and Selank can reduce anxiety and elevate serotonin levels in rats, with Selank proving to be the more effective of the two.

In Russia, Selank has been sanctioned for the management of generalized anxiety disorder (GAD) and as a nootropic, although it is yet to receive FDA approval for any medical applications. Nonetheless, this compound is widely available across various countries, often marketed as a "nutritional supplement."

While the exact mechanisms by which Selank operates remain partially understood, it is believed to stabilize enkephalins?natural peptides in the bloodstream that may alleviate stress responses. However, one study involving mice showed no such stabilization or significant anti-anxiety effects post-Selank administration.

Some cellular studies suggest Selank may engage with GABA receptors, typically associated with sedative properties. Mice treated with Selank displayed increased activity in GABA-dependent inhibitory neurons, indicating a reduction in brain activity akin to sedative effects.

Moreover, reports indicate heightened levels of BDNF (brain-derived neurotrophic factor), essential for brain development and linked to learning and memory. This might provide insight into some of Selank's purported cognitive advantages.

Selank also appears to influence neurotransmitter levels, such as norepinephrine, dopamine, and serotonin, which are crucial for motivation, focus, and pleasure. However, findings from one study indicated Selank raised norepinephrine while decreasing dopamine and serotonin, whereas other studies showed an increase in both norepinephrine and dopamine without affecting serotonin levels. Thus, the specifics of Selank's effects and mechanisms remain unclear.

A preliminary clinical trial with 62 participants revealed that those receiving Selank experienced a notable reduction in anxiety symptoms, particularly among individuals with pre-existing anxiety disorders. Another study involving 60 patients with anxiety and phobias corroborated these findings, demonstrating lasting effects for up to a week after treatment.

In a trial with 70 anxiety patients, Selank enhanced the effectiveness of phenazepam (a banned anti-anxiety medication in certain U.S. states) while minimizing adverse effects like drowsiness and memory loss.

Animal studies also support these findings, showing that Selank reduces anxiety in mice, especially in those with higher initial anxiety levels. A four-week daily treatment in rats resulted in significant anti-anxiety outcomes.

Though evidence is still limited, these results suggest Selank may offer potential relief from anxiety. However, further research is essential to validate its safety and efficacy for human subjects. Individuals experiencing anxiety should consult healthcare professionals before considering Selank as a treatment option.

In a 30-day study, Selank was linked to the stabilization of memory traces in rats, although the assessment methods were unclear, as memory traces do not correspond to specific brain areas. Another study indicated Selank might help preserve memory in monkeys. However, conclusive human studies are lacking, and the effects on healthy individuals remain undefined, necessitating further research regarding its safety over short and long periods.

Research indicated that Selank administration in rats with toxin-induced brain damage led to the restoration of normal brain activity.

Selank has been observed to alleviate depressive symptoms (as evidenced by immobility during forced swimming tests) in mice, showing increased effectiveness at lower doses.

In preliminary animal studies, Selank injections were found to elevate antioxidant levels in the livers of stressed mice.

A study involving sedated cats revealed that Selank decreased blood pressure by approximately 30% for a short duration while increasing brain blood flow by about 24% for up to 10 minutes. While intriguing, these findings suggest that Selank's effects on blood circulation may be transient, warranting further exploration of their medical relevance to healthy humans.

Anxiety is a prevalent symptom of alcohol withdrawal. In a study, rats given a 10% ethanol solution as their sole water source for 24 weeks exhibited reduced anxiety 48 hours post-withdrawal when treated with Selank.

In a study with rats on a high-fat diet, those treated with Selank showed 35% less weight gain, with total cholesterol levels dropping by over 58% and blood glucose levels reduced by 23.5%.

In one study, mice with breast cancer treated with daily doses of Selank experienced slower tumor growth and longer lifespans compared to untreated counterparts. However, this initial finding does not imply Selank's efficacy in cancer treatment; extensive research is necessary to substantiate these early results before any clinical applications can be made. Selank should not replace conventional cancer treatments under any circumstances.

After Selank treatment, mouse spleens exhibited elevated levels of various inflammatory response genes, potentially indicating some protective benefits against inflammation-related damage.

Selank has been reported to reduce stomach ulcer sizes in animal models, possibly by enhancing lymphatic flow to the stomach, an essential component of the immune system. However, further human studies are required to validate this effect and investigate its underlying mechanisms.

Selank has been shown to increase IL-6 levels in blood cells from patients with depression. IL-6 is an inflammatory protein known to aid in fighting infections. Additionally, in one cell-based study, Selank stimulated the release of interferons, which act as antiviral agents. While some speculate that Selank may offer protection against viral infections, results from an animal study involving virus-infected mice did not demonstrate any antiviral advantages, raising questions about this potential application.